Quantify Technology locks in major MOU with Greaton Group

Published 21-MAR-2018 10:34 A.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Quantify Technology Holdings Limited (ASX:QFY) has announced a multi-faceted Memorandum of Understanding with Greaton Group which includes Greaton, Haneco Lighting and Lucesco Lighting.

The Greaton Group’s portfolio spans hotels, residential and commercial development projects, and brings new designs and architectural partnerships to the Australian property market. The Group recently secured the A$730 million development project “The Ribbon” at Darling Harbour, Sydney, as well as other multi-million-dollar construction projects.

The two parties have agreed to evaluate licensing opportunities for QFY’s platform in new verticals while at the same time developing complementary IoT products and solutions, with potential sales and distribution via Greaton Group’s existing network of over 600 partners.

In addition, the agreement makes reference to QFY potentially gaining access to Greaton Group’s volume manufacturing capabilities, both in Australia and China. This is a key factor for the small cap, which has been planning to grow its manufacturing capabilities in response to the increase in demand for its products — allowing it to simultaneously minimize its cost of production for hardware.

A synergistic partnership

There are some obvious opportunities for synergy in QFY’s latest partnership — in particular the deal offers a substantial sales opportunity to supply Greaton’s developments with its Q Device and other intelligent building products.

Greaton has secured a large urban regeneration project in the Adelaide CBD, as well as the $300 million West Franklin project, and is currently developing a $260 million residential site in Sydney suburb Epping. Its pipeline of major projects recommends it as an ideal partner for QFY to secure.

A further mutually beneficial aspect of the agreement is the stipulation towards licensing QFY’s existing technology, development expertise and IP. This makes sense since Greaton Group plan to utilise the company’s expertise to assist in the creation of next generation lighting solutions for its two lighting companies — Haneco Lighting and Lucesco Lighting.

With the MOU in place, QFY expect to receive an increase in income from either sales of its existing hardware and its Qumulus cloud solutions or from new technology development projects, plus royalties from licensing of the company’s technology.

“This is an exciting time for Quantify Technology. We are now able to demonstrate that the Company can deliver more than just products for our Intelligent Building solution. Our Qumulus cloud platform, and our engineering expertise, provide other companies tools they can harness to enter the IoT market with their own unique offerings,” QFY Managing Director Mark Lapins said.

However this remains an early stage play and as such any investment decision should be made with caution and professional financial advice should be sought.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X